Global Opioid Use Disorder Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Opioid Use Disorder market size was valued at USD 1798.3 million in 2023 and is forecast to a readjusted size of USD 2608.2 million by 2030 with a CAGR of 5.5% during review period.
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Opioid Use Disorder industry chain, the market status of Moderate Pain Treatment (Buprenorphine, Methadone), Severe Pain Treatment (Buprenorphine, Methadone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Opioid Use Disorder.
Regionally, the report analyzes the Opioid Use Disorder markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Opioid Use Disorder market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Opioid Use Disorder market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Opioid Use Disorder industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Buprenorphine, Methadone).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Opioid Use Disorder market.
Regional Analysis: The report involves examining the Opioid Use Disorder market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Opioid Use Disorder market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Opioid Use Disorder:
Company Analysis: Report covers individual Opioid Use Disorder players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Opioid Use Disorder This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Moderate Pain Treatment, Severe Pain Treatment).
Technology Analysis: Report covers specific technologies relevant to Opioid Use Disorder. It assesses the current state, advancements, and potential future developments in Opioid Use Disorder areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Opioid Use Disorder market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Opioid Use Disorder market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Opioid Use Disorder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Opioid Use Disorder, with revenue, gross margin and global market share of Opioid Use Disorder from 2019 to 2024.
Chapter 3, the Opioid Use Disorder competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Opioid Use Disorder market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioid Use Disorder.
Chapter 13, to describe Opioid Use Disorder research findings and conclusion.
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Opioid Use Disorder industry chain, the market status of Moderate Pain Treatment (Buprenorphine, Methadone), Severe Pain Treatment (Buprenorphine, Methadone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Opioid Use Disorder.
Regionally, the report analyzes the Opioid Use Disorder markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Opioid Use Disorder market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Opioid Use Disorder market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Opioid Use Disorder industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Buprenorphine, Methadone).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Opioid Use Disorder market.
Regional Analysis: The report involves examining the Opioid Use Disorder market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Opioid Use Disorder market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Opioid Use Disorder:
Company Analysis: Report covers individual Opioid Use Disorder players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Opioid Use Disorder This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Moderate Pain Treatment, Severe Pain Treatment).
Technology Analysis: Report covers specific technologies relevant to Opioid Use Disorder. It assesses the current state, advancements, and potential future developments in Opioid Use Disorder areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Opioid Use Disorder market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Opioid Use Disorder market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Buprenorphine
- Methadone
- Naltrexone
- Moderate Pain Treatment
- Severe Pain Treatment
- Indivior
- Alkermes
- Titan Pharmaceuticals
- Hikma Pharmaceuticals
- Teva Pharmaceuticals
- MediciNova
- Orexo
- Camurus
- Omeros
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Opioid Use Disorder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Opioid Use Disorder, with revenue, gross margin and global market share of Opioid Use Disorder from 2019 to 2024.
Chapter 3, the Opioid Use Disorder competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Opioid Use Disorder market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioid Use Disorder.
Chapter 13, to describe Opioid Use Disorder research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Opioid Use Disorder
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Opioid Use Disorder by Type
1.3.1 Overview: Global Opioid Use Disorder Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Opioid Use Disorder Consumption Value Market Share by Type in 2023
1.3.3 Buprenorphine
1.3.4 Methadone
1.3.5 Naltrexone
1.4 Global Opioid Use Disorder Market by Application
1.4.1 Overview: Global Opioid Use Disorder Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Moderate Pain Treatment
1.4.3 Severe Pain Treatment
1.5 Global Opioid Use Disorder Market Size & Forecast
1.6 Global Opioid Use Disorder Market Size and Forecast by Region
1.6.1 Global Opioid Use Disorder Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Opioid Use Disorder Market Size by Region, (2019-2030)
1.6.3 North America Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.4 Europe Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.6 South America Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Opioid Use Disorder Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Indivior
2.1.1 Indivior Details
2.1.2 Indivior Major Business
2.1.3 Indivior Opioid Use Disorder Product and Solutions
2.1.4 Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Indivior Recent Developments and Future Plans
2.2 Alkermes
2.2.1 Alkermes Details
2.2.2 Alkermes Major Business
2.2.3 Alkermes Opioid Use Disorder Product and Solutions
2.2.4 Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Alkermes Recent Developments and Future Plans
2.3 Titan Pharmaceuticals
2.3.1 Titan Pharmaceuticals Details
2.3.2 Titan Pharmaceuticals Major Business
2.3.3 Titan Pharmaceuticals Opioid Use Disorder Product and Solutions
2.3.4 Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Titan Pharmaceuticals Recent Developments and Future Plans
2.4 Hikma Pharmaceuticals
2.4.1 Hikma Pharmaceuticals Details
2.4.2 Hikma Pharmaceuticals Major Business
2.4.3 Hikma Pharmaceuticals Opioid Use Disorder Product and Solutions
2.4.4 Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.5 Teva Pharmaceuticals
2.5.1 Teva Pharmaceuticals Details
2.5.2 Teva Pharmaceuticals Major Business
2.5.3 Teva Pharmaceuticals Opioid Use Disorder Product and Solutions
2.5.4 Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.6 MediciNova
2.6.1 MediciNova Details
2.6.2 MediciNova Major Business
2.6.3 MediciNova Opioid Use Disorder Product and Solutions
2.6.4 MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 MediciNova Recent Developments and Future Plans
2.7 Orexo
2.7.1 Orexo Details
2.7.2 Orexo Major Business
2.7.3 Orexo Opioid Use Disorder Product and Solutions
2.7.4 Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Orexo Recent Developments and Future Plans
2.8 Camurus
2.8.1 Camurus Details
2.8.2 Camurus Major Business
2.8.3 Camurus Opioid Use Disorder Product and Solutions
2.8.4 Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Camurus Recent Developments and Future Plans
2.9 Omeros
2.9.1 Omeros Details
2.9.2 Omeros Major Business
2.9.3 Omeros Opioid Use Disorder Product and Solutions
2.9.4 Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Omeros Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Opioid Use Disorder Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Opioid Use Disorder by Company Revenue
3.2.2 Top 3 Opioid Use Disorder Players Market Share in 2023
3.2.3 Top 6 Opioid Use Disorder Players Market Share in 2023
3.3 Opioid Use Disorder Market: Overall Company Footprint Analysis
3.3.1 Opioid Use Disorder Market: Region Footprint
3.3.2 Opioid Use Disorder Market: Company Product Type Footprint
3.3.3 Opioid Use Disorder Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Opioid Use Disorder Consumption Value and Market Share by Type (2019-2024)
4.2 Global Opioid Use Disorder Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Opioid Use Disorder Consumption Value Market Share by Application (2019-2024)
5.2 Global Opioid Use Disorder Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Opioid Use Disorder Consumption Value by Type (2019-2030)
6.2 North America Opioid Use Disorder Consumption Value by Application (2019-2030)
6.3 North America Opioid Use Disorder Market Size by Country
6.3.1 North America Opioid Use Disorder Consumption Value by Country (2019-2030)
6.3.2 United States Opioid Use Disorder Market Size and Forecast (2019-2030)
6.3.3 Canada Opioid Use Disorder Market Size and Forecast (2019-2030)
6.3.4 Mexico Opioid Use Disorder Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Opioid Use Disorder Consumption Value by Type (2019-2030)
7.2 Europe Opioid Use Disorder Consumption Value by Application (2019-2030)
7.3 Europe Opioid Use Disorder Market Size by Country
7.3.1 Europe Opioid Use Disorder Consumption Value by Country (2019-2030)
7.3.2 Germany Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.3 France Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.5 Russia Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.6 Italy Opioid Use Disorder Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Opioid Use Disorder Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Opioid Use Disorder Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Opioid Use Disorder Market Size by Region
8.3.1 Asia-Pacific Opioid Use Disorder Consumption Value by Region (2019-2030)
8.3.2 China Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.3 Japan Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.4 South Korea Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.5 India Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.7 Australia Opioid Use Disorder Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Opioid Use Disorder Consumption Value by Type (2019-2030)
9.2 South America Opioid Use Disorder Consumption Value by Application (2019-2030)
9.3 South America Opioid Use Disorder Market Size by Country
9.3.1 South America Opioid Use Disorder Consumption Value by Country (2019-2030)
9.3.2 Brazil Opioid Use Disorder Market Size and Forecast (2019-2030)
9.3.3 Argentina Opioid Use Disorder Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Opioid Use Disorder Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Opioid Use Disorder Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Opioid Use Disorder Market Size by Country
10.3.1 Middle East & Africa Opioid Use Disorder Consumption Value by Country (2019-2030)
10.3.2 Turkey Opioid Use Disorder Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Opioid Use Disorder Market Size and Forecast (2019-2030)
10.3.4 UAE Opioid Use Disorder Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Opioid Use Disorder Market Drivers
11.2 Opioid Use Disorder Market Restraints
11.3 Opioid Use Disorder Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Opioid Use Disorder Industry Chain
12.2 Opioid Use Disorder Upstream Analysis
12.3 Opioid Use Disorder Midstream Analysis
12.4 Opioid Use Disorder Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Opioid Use Disorder
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Opioid Use Disorder by Type
1.3.1 Overview: Global Opioid Use Disorder Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Opioid Use Disorder Consumption Value Market Share by Type in 2023
1.3.3 Buprenorphine
1.3.4 Methadone
1.3.5 Naltrexone
1.4 Global Opioid Use Disorder Market by Application
1.4.1 Overview: Global Opioid Use Disorder Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Moderate Pain Treatment
1.4.3 Severe Pain Treatment
1.5 Global Opioid Use Disorder Market Size & Forecast
1.6 Global Opioid Use Disorder Market Size and Forecast by Region
1.6.1 Global Opioid Use Disorder Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Opioid Use Disorder Market Size by Region, (2019-2030)
1.6.3 North America Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.4 Europe Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.6 South America Opioid Use Disorder Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Opioid Use Disorder Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Indivior
2.1.1 Indivior Details
2.1.2 Indivior Major Business
2.1.3 Indivior Opioid Use Disorder Product and Solutions
2.1.4 Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Indivior Recent Developments and Future Plans
2.2 Alkermes
2.2.1 Alkermes Details
2.2.2 Alkermes Major Business
2.2.3 Alkermes Opioid Use Disorder Product and Solutions
2.2.4 Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Alkermes Recent Developments and Future Plans
2.3 Titan Pharmaceuticals
2.3.1 Titan Pharmaceuticals Details
2.3.2 Titan Pharmaceuticals Major Business
2.3.3 Titan Pharmaceuticals Opioid Use Disorder Product and Solutions
2.3.4 Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Titan Pharmaceuticals Recent Developments and Future Plans
2.4 Hikma Pharmaceuticals
2.4.1 Hikma Pharmaceuticals Details
2.4.2 Hikma Pharmaceuticals Major Business
2.4.3 Hikma Pharmaceuticals Opioid Use Disorder Product and Solutions
2.4.4 Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.5 Teva Pharmaceuticals
2.5.1 Teva Pharmaceuticals Details
2.5.2 Teva Pharmaceuticals Major Business
2.5.3 Teva Pharmaceuticals Opioid Use Disorder Product and Solutions
2.5.4 Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.6 MediciNova
2.6.1 MediciNova Details
2.6.2 MediciNova Major Business
2.6.3 MediciNova Opioid Use Disorder Product and Solutions
2.6.4 MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 MediciNova Recent Developments and Future Plans
2.7 Orexo
2.7.1 Orexo Details
2.7.2 Orexo Major Business
2.7.3 Orexo Opioid Use Disorder Product and Solutions
2.7.4 Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Orexo Recent Developments and Future Plans
2.8 Camurus
2.8.1 Camurus Details
2.8.2 Camurus Major Business
2.8.3 Camurus Opioid Use Disorder Product and Solutions
2.8.4 Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Camurus Recent Developments and Future Plans
2.9 Omeros
2.9.1 Omeros Details
2.9.2 Omeros Major Business
2.9.3 Omeros Opioid Use Disorder Product and Solutions
2.9.4 Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Omeros Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Opioid Use Disorder Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Opioid Use Disorder by Company Revenue
3.2.2 Top 3 Opioid Use Disorder Players Market Share in 2023
3.2.3 Top 6 Opioid Use Disorder Players Market Share in 2023
3.3 Opioid Use Disorder Market: Overall Company Footprint Analysis
3.3.1 Opioid Use Disorder Market: Region Footprint
3.3.2 Opioid Use Disorder Market: Company Product Type Footprint
3.3.3 Opioid Use Disorder Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Opioid Use Disorder Consumption Value and Market Share by Type (2019-2024)
4.2 Global Opioid Use Disorder Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Opioid Use Disorder Consumption Value Market Share by Application (2019-2024)
5.2 Global Opioid Use Disorder Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Opioid Use Disorder Consumption Value by Type (2019-2030)
6.2 North America Opioid Use Disorder Consumption Value by Application (2019-2030)
6.3 North America Opioid Use Disorder Market Size by Country
6.3.1 North America Opioid Use Disorder Consumption Value by Country (2019-2030)
6.3.2 United States Opioid Use Disorder Market Size and Forecast (2019-2030)
6.3.3 Canada Opioid Use Disorder Market Size and Forecast (2019-2030)
6.3.4 Mexico Opioid Use Disorder Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Opioid Use Disorder Consumption Value by Type (2019-2030)
7.2 Europe Opioid Use Disorder Consumption Value by Application (2019-2030)
7.3 Europe Opioid Use Disorder Market Size by Country
7.3.1 Europe Opioid Use Disorder Consumption Value by Country (2019-2030)
7.3.2 Germany Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.3 France Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.5 Russia Opioid Use Disorder Market Size and Forecast (2019-2030)
7.3.6 Italy Opioid Use Disorder Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Opioid Use Disorder Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Opioid Use Disorder Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Opioid Use Disorder Market Size by Region
8.3.1 Asia-Pacific Opioid Use Disorder Consumption Value by Region (2019-2030)
8.3.2 China Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.3 Japan Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.4 South Korea Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.5 India Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Opioid Use Disorder Market Size and Forecast (2019-2030)
8.3.7 Australia Opioid Use Disorder Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Opioid Use Disorder Consumption Value by Type (2019-2030)
9.2 South America Opioid Use Disorder Consumption Value by Application (2019-2030)
9.3 South America Opioid Use Disorder Market Size by Country
9.3.1 South America Opioid Use Disorder Consumption Value by Country (2019-2030)
9.3.2 Brazil Opioid Use Disorder Market Size and Forecast (2019-2030)
9.3.3 Argentina Opioid Use Disorder Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Opioid Use Disorder Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Opioid Use Disorder Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Opioid Use Disorder Market Size by Country
10.3.1 Middle East & Africa Opioid Use Disorder Consumption Value by Country (2019-2030)
10.3.2 Turkey Opioid Use Disorder Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Opioid Use Disorder Market Size and Forecast (2019-2030)
10.3.4 UAE Opioid Use Disorder Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Opioid Use Disorder Market Drivers
11.2 Opioid Use Disorder Market Restraints
11.3 Opioid Use Disorder Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Opioid Use Disorder Industry Chain
12.2 Opioid Use Disorder Upstream Analysis
12.3 Opioid Use Disorder Midstream Analysis
12.4 Opioid Use Disorder Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Opioid Use Disorder Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Opioid Use Disorder Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Opioid Use Disorder Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Opioid Use Disorder Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Indivior Company Information, Head Office, and Major Competitors
Table 6. Indivior Major Business
Table 7. Indivior Opioid Use Disorder Product and Solutions
Table 8. Indivior Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Indivior Recent Developments and Future Plans
Table 10. Alkermes Company Information, Head Office, and Major Competitors
Table 11. Alkermes Major Business
Table 12. Alkermes Opioid Use Disorder Product and Solutions
Table 13. Alkermes Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Alkermes Recent Developments and Future Plans
Table 15. Titan Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Titan Pharmaceuticals Major Business
Table 17. Titan Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 18. Titan Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Titan Pharmaceuticals Recent Developments and Future Plans
Table 20. Hikma Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Hikma Pharmaceuticals Major Business
Table 22. Hikma Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 23. Hikma Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Hikma Pharmaceuticals Recent Developments and Future Plans
Table 25. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Teva Pharmaceuticals Major Business
Table 27. Teva Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 28. Teva Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Teva Pharmaceuticals Recent Developments and Future Plans
Table 30. MediciNova Company Information, Head Office, and Major Competitors
Table 31. MediciNova Major Business
Table 32. MediciNova Opioid Use Disorder Product and Solutions
Table 33. MediciNova Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. MediciNova Recent Developments and Future Plans
Table 35. Orexo Company Information, Head Office, and Major Competitors
Table 36. Orexo Major Business
Table 37. Orexo Opioid Use Disorder Product and Solutions
Table 38. Orexo Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Orexo Recent Developments and Future Plans
Table 40. Camurus Company Information, Head Office, and Major Competitors
Table 41. Camurus Major Business
Table 42. Camurus Opioid Use Disorder Product and Solutions
Table 43. Camurus Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Camurus Recent Developments and Future Plans
Table 45. Omeros Company Information, Head Office, and Major Competitors
Table 46. Omeros Major Business
Table 47. Omeros Opioid Use Disorder Product and Solutions
Table 48. Omeros Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Omeros Recent Developments and Future Plans
Table 50. Global Opioid Use Disorder Revenue (USD Million) by Players (2019-2024)
Table 51. Global Opioid Use Disorder Revenue Share by Players (2019-2024)
Table 52. Breakdown of Opioid Use Disorder by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Opioid Use Disorder, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Opioid Use Disorder Players
Table 55. Opioid Use Disorder Market: Company Product Type Footprint
Table 56. Opioid Use Disorder Market: Company Product Application Footprint
Table 57. Opioid Use Disorder New Market Entrants and Barriers to Market Entry
Table 58. Opioid Use Disorder Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Opioid Use Disorder Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Opioid Use Disorder Consumption Value Share by Type (2019-2024)
Table 61. Global Opioid Use Disorder Consumption Value Forecast by Type (2025-2030)
Table 62. Global Opioid Use Disorder Consumption Value by Application (2019-2024)
Table 63. Global Opioid Use Disorder Consumption Value Forecast by Application (2025-2030)
Table 64. North America Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Opioid Use Disorder Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Opioid Use Disorder Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Opioid Use Disorder Raw Material
Table 95. Key Suppliers of Opioid Use Disorder Raw Materials
Table 1. Global Opioid Use Disorder Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Opioid Use Disorder Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Opioid Use Disorder Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Opioid Use Disorder Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Indivior Company Information, Head Office, and Major Competitors
Table 6. Indivior Major Business
Table 7. Indivior Opioid Use Disorder Product and Solutions
Table 8. Indivior Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Indivior Recent Developments and Future Plans
Table 10. Alkermes Company Information, Head Office, and Major Competitors
Table 11. Alkermes Major Business
Table 12. Alkermes Opioid Use Disorder Product and Solutions
Table 13. Alkermes Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Alkermes Recent Developments and Future Plans
Table 15. Titan Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Titan Pharmaceuticals Major Business
Table 17. Titan Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 18. Titan Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Titan Pharmaceuticals Recent Developments and Future Plans
Table 20. Hikma Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Hikma Pharmaceuticals Major Business
Table 22. Hikma Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 23. Hikma Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Hikma Pharmaceuticals Recent Developments and Future Plans
Table 25. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Teva Pharmaceuticals Major Business
Table 27. Teva Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 28. Teva Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Teva Pharmaceuticals Recent Developments and Future Plans
Table 30. MediciNova Company Information, Head Office, and Major Competitors
Table 31. MediciNova Major Business
Table 32. MediciNova Opioid Use Disorder Product and Solutions
Table 33. MediciNova Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. MediciNova Recent Developments and Future Plans
Table 35. Orexo Company Information, Head Office, and Major Competitors
Table 36. Orexo Major Business
Table 37. Orexo Opioid Use Disorder Product and Solutions
Table 38. Orexo Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Orexo Recent Developments and Future Plans
Table 40. Camurus Company Information, Head Office, and Major Competitors
Table 41. Camurus Major Business
Table 42. Camurus Opioid Use Disorder Product and Solutions
Table 43. Camurus Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Camurus Recent Developments and Future Plans
Table 45. Omeros Company Information, Head Office, and Major Competitors
Table 46. Omeros Major Business
Table 47. Omeros Opioid Use Disorder Product and Solutions
Table 48. Omeros Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Omeros Recent Developments and Future Plans
Table 50. Global Opioid Use Disorder Revenue (USD Million) by Players (2019-2024)
Table 51. Global Opioid Use Disorder Revenue Share by Players (2019-2024)
Table 52. Breakdown of Opioid Use Disorder by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Opioid Use Disorder, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Opioid Use Disorder Players
Table 55. Opioid Use Disorder Market: Company Product Type Footprint
Table 56. Opioid Use Disorder Market: Company Product Application Footprint
Table 57. Opioid Use Disorder New Market Entrants and Barriers to Market Entry
Table 58. Opioid Use Disorder Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Opioid Use Disorder Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Opioid Use Disorder Consumption Value Share by Type (2019-2024)
Table 61. Global Opioid Use Disorder Consumption Value Forecast by Type (2025-2030)
Table 62. Global Opioid Use Disorder Consumption Value by Application (2019-2024)
Table 63. Global Opioid Use Disorder Consumption Value Forecast by Application (2025-2030)
Table 64. North America Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Opioid Use Disorder Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Opioid Use Disorder Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Opioid Use Disorder Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Opioid Use Disorder Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Opioid Use Disorder Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Opioid Use Disorder Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Opioid Use Disorder Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Opioid Use Disorder Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Opioid Use Disorder Raw Material
Table 95. Key Suppliers of Opioid Use Disorder Raw Materials
LIST OF FIGURES
Figure 1. Opioid Use Disorder Picture
Figure 2. Global Opioid Use Disorder Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Opioid Use Disorder Consumption Value Market Share by Type in 2023
Figure 4. Buprenorphine
Figure 5. Methadone
Figure 6. Naltrexone
Figure 7. Global Opioid Use Disorder Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Opioid Use Disorder Consumption Value Market Share by Application in 2023
Figure 9. Moderate Pain Treatment Picture
Figure 10. Severe Pain Treatment Picture
Figure 11. Global Opioid Use Disorder Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Opioid Use Disorder Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Opioid Use Disorder Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Opioid Use Disorder Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Opioid Use Disorder Consumption Value Market Share by Region in 2023
Figure 16. North America Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Opioid Use Disorder Revenue Share by Players in 2023
Figure 22. Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Opioid Use Disorder Market Share in 2023
Figure 24. Global Top 6 Players Opioid Use Disorder Market Share in 2023
Figure 25. Global Opioid Use Disorder Consumption Value Share by Type (2019-2024)
Figure 26. Global Opioid Use Disorder Market Share Forecast by Type (2025-2030)
Figure 27. Global Opioid Use Disorder Consumption Value Share by Application (2019-2024)
Figure 28. Global Opioid Use Disorder Market Share Forecast by Application (2025-2030)
Figure 29. North America Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 39. France Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Opioid Use Disorder Consumption Value Market Share by Region (2019-2030)
Figure 46. China Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 49. India Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 63. Opioid Use Disorder Market Drivers
Figure 64. Opioid Use Disorder Market Restraints
Figure 65. Opioid Use Disorder Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Opioid Use Disorder in 2023
Figure 68. Manufacturing Process Analysis of Opioid Use Disorder
Figure 69. Opioid Use Disorder Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Opioid Use Disorder Picture
Figure 2. Global Opioid Use Disorder Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Opioid Use Disorder Consumption Value Market Share by Type in 2023
Figure 4. Buprenorphine
Figure 5. Methadone
Figure 6. Naltrexone
Figure 7. Global Opioid Use Disorder Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Opioid Use Disorder Consumption Value Market Share by Application in 2023
Figure 9. Moderate Pain Treatment Picture
Figure 10. Severe Pain Treatment Picture
Figure 11. Global Opioid Use Disorder Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Opioid Use Disorder Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Opioid Use Disorder Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Opioid Use Disorder Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Opioid Use Disorder Consumption Value Market Share by Region in 2023
Figure 16. North America Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Opioid Use Disorder Revenue Share by Players in 2023
Figure 22. Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Opioid Use Disorder Market Share in 2023
Figure 24. Global Top 6 Players Opioid Use Disorder Market Share in 2023
Figure 25. Global Opioid Use Disorder Consumption Value Share by Type (2019-2024)
Figure 26. Global Opioid Use Disorder Market Share Forecast by Type (2025-2030)
Figure 27. Global Opioid Use Disorder Consumption Value Share by Application (2019-2024)
Figure 28. Global Opioid Use Disorder Market Share Forecast by Application (2025-2030)
Figure 29. North America Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 39. France Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Opioid Use Disorder Consumption Value Market Share by Region (2019-2030)
Figure 46. China Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 49. India Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Opioid Use Disorder Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Opioid Use Disorder Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Opioid Use Disorder Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Opioid Use Disorder Consumption Value (2019-2030) & (USD Million)
Figure 63. Opioid Use Disorder Market Drivers
Figure 64. Opioid Use Disorder Market Restraints
Figure 65. Opioid Use Disorder Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Opioid Use Disorder in 2023
Figure 68. Manufacturing Process Analysis of Opioid Use Disorder
Figure 69. Opioid Use Disorder Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
